Shlomo Lustig

Title: Shlomo Lustig: Innovator in Poxvirus Vaccine Development

Introduction

Shlomo Lustig is a notable inventor based in Ramat Gan, Israel. He has made significant contributions to the field of vaccine development, particularly focusing on poxvirus subunit vaccines. With a total of two patents to his name, Lustig's work is pivotal in advancing medical science.

Latest Patents

Lustig's latest patents include compositions, methods, and kits relating to poxvirus subunit vaccines. One of his inventions is directed to a poxvirus vaccine comprising a soluble truncated poxvirus envelope protein. This invention also encompasses a vaccine that includes a nucleic acid encoding such proteins. Additionally, it features an antibody that specifically binds to the proteins and nucleic acid encoding them. The methods outlined in his patents aim to prevent and treat poxvirus infections using the aforementioned vaccine, antibody, protein, and nucleic acid.

Career Highlights

Throughout his career, Lustig has worked with prestigious institutions such as the University of Pennsylvania and the National Institutes of Health, a component of the U.S. Department of Health & Human Services. His experience in these organizations has greatly influenced his research and innovations in vaccine development.

Collaborations

Lustig has collaborated with notable colleagues, including Gary H. Cohen and John Charles Whitbeck. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Shlomo Lustig's contributions to poxvirus vaccine development highlight his innovative spirit and dedication to medical science. His patents and collaborations reflect a commitment to improving public health through advanced vaccine technologies.